How has the lifespan of people with spina bifida changed over the decades?

Publicly released:
International
Photo by Jon Tyson on Unsplash
Photo by Jon Tyson on Unsplash

The lifespan of people with spina bifida has improved over the past 70 years, but not any faster than the general population, according to international researchers who say there is likely much more to be done to improve health outcomes for people with the condition. Spina bifida is a birth defect impacting the development of the spine that often leads to lifelong mobility issues. The researchers identified 942 people living with spina bifida in the US from 1950 to 2020, and compared their mortality rate with 9420 unaffected people matched by birth year, sex and residential area. The researchers say survival in the spina bifida cohort improved in parallel to the general population over the decades, but survival remained 24-fold worse during infancy down to 8-fold worse in their sixth decade of life. The researchers say this suggests the improved life expectancy of people with spina bifida may be mostly as a result of general healthcare improvements - especially in infant mortality - rather than specific spina bifida care progress and people with the condition likely still have unmet healthcare needs reducing their lifespan.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research JAMA, Web page The URL will go live after the embargo ends
Journal/
conference:
JAMA Pediatrics
Research:Paper
Organisation/s: University of Utah, USA
Funder: Dr Schaeffer is supported in part by career development award NIH K08 DK00119535. Partial support for all datasets within the Utah Population Database (UPDB) was provided by the University of Utah Huntsman Cancer Institute and the Huntsman Cancer Institute Cancer Center Support grant (P30 CA2014) from the National Cancer Institute. Dr Schlaepfer is supported in part by TL1 DK147552, which supported design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. The computational resources used for collection, management, analysis, and interpretation of the data were partially funded by the US National Institutes of Health (NIH, Share Instrumentation Grant 1S10OD021644-011A1).We also acknowledge partial support for the UPDB through grant P30 CA2014 from the National Cancer Institute and University of Utah and from the University of Utah’s program in Personalized Health and Utah Clinical and Translational Science Institute for collection, management, analysis, and interpretation of the data within UPDB.
Media Contact/s
Contact details are only visible to registered journalists.